Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).

Development of safe and effective RSV vaccine by modified CD4 epitope in G protein core fragment (Gcf).

Respiratory syncytial virus (RSV) is a major cause of respiratory tract infection in infants and young children worldwide, but currently no safe and effective vaccine is available. The RSV G glycoprotein (RSVG), a major attachment protein, is an important target for the induction of protective immun...

Full description

Bibliographic Details
Main Authors: In Su Cheon, Byoung-Shik Shim, Sung-Moo Park, Youngjoo Choi, Ji Eun Jang, Dae Im Jung, Jae-Ouk Kim, Jun Chang, Cheol-Heui Yun, Man Ki Song
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3988050?pdf=render

Internet

http://europepmc.org/articles/PMC3988050?pdf=render

Similar Items